To determine whether NBO is involved in complement C3‐mediated brain injury after ICH, we treated ICH patients with (ICH + NBO) or without (ICH) NBO therapy and examined plasma C3 levels and subsequent neurological functions. Here, C3 is linked to chronic recurrent multifocal osteomyelitis.